| Trademark Snap Shot Amendment & Mail Processing Stylesheet (Table presents the data on Amendment & Mail Processing Complete) |
|||
OVERVIEW |
|||
| SERIAL NUMBER | 86242357 | FILING DATE | 04/04/2014 |
| REG NUMBER | 0000000 | REG DATE | N/A |
| REGISTER | PRINCIPAL | MARK TYPE | TRADEMARK |
| INTL REG # | N/A | INTL REG DATE | N/A |
| TM ATTORNEY | WANG, WEN HSING |
L.O. ASSIGNED | 108 |
PUB INFORMATION |
|||
| RUN DATE | 06/25/2014 | ||
| PUB DATE | N/A | ||
| STATUS | 647-EXAMINERS AMENDMENT - MAILED | ||
| STATUS DATE | 06/24/2014 | ||
| LITERAL MARK ELEMENT | ZARXIO FILGRASTIM | ||
| DATE ABANDONED | N/A | DATE CANCELLED | N/A |
| SECTION 2F | NO | SECTION 2F IN PART | NO |
| SECTION 8 | NO | SECTION 8 IN PART | NO |
| SECTION 15 | NO | REPUB 12C | N/A |
| RENEWAL FILED | NO | RENEWAL DATE | N/A |
| DATE AMEND REG | N/A | ||
FILING BASIS |
|||||
| FILED BASIS | CURRENT BASIS | AMENDED BASIS | |||
| 1 (a) | NO | 1 (a) | NO | 1 (a) | NO |
| 1 (b) | YES | 1 (b) | YES | 1 (b) | NO |
| 44D | NO | 44D | NO | 44D | NO |
| 44E | NO | 44E | NO | 44E | NO |
| 66A | NO | 66A | NO | ||
| NO BASIS | NO | NO BASIS | NO | ||
MARK DATA |
|
| STANDARD CHARACTER MARK | NO |
| LITERAL MARK ELEMENT | ZARXIO FILGRASTIM |
| MARK DRAWING CODE | 3-AN ILLUSTRATION DRAWING WHICH INCLUDES WORD(S)/LETTER(S)/NUMBER(S) |
| COLOR DRAWING FLAG | YES |
CURRENT OWNER INFORMATION |
|
| PARTY TYPE | 10-ORIGINAL APPLICANT |
| NAME | Novartis AG |
| ADDRESS | CH-4002 Basel, |
| ENTITY | 03-CORPORATION |
| CITIZENSHIP | Switzerland |
GOODS AND SERVICES |
|
| INTERNATIONAL CLASS | 005 |
| DESCRIPTION TEXT | Pharmaceutical preparations for use in stimulating white blood cell production available only by prescription |
GOODS AND SERVICES CLASSIFICATION |
|||||||
| INTERNATIONAL CLASS | 005 | FIRST USE DATE | NONE | FIRST USE IN COMMERCE DATE | NONE | CLASS STATUS | 6-ACTIVE |
MISCELLANEOUS INFORMATION/STATEMENTS |
|
| CHANGE IN REGISTRATION | NO |
| COLORS CLAIMED STATEMENT | The color(s) blue, light gray, dark gray and white is/are claimed as a feature of the mark. |
| DISCLAIMER W/PREDETER TXT | "FILGRASTIM" |
| DESCRIPTION OF MARK | The mark consists of three overlapping small, medium and large teardrops followed by the word "ZARXIO" over and right-justified with the term "FILGRASTIM"; the large teardrop is in blue with a spot of gradient white on the left side, the letters "ZARXI" and FILGRASTIM are in blue, the medium teardrop is in light gray, the letter "O" is in dark gray and the small teardrop is in white. |
PROSECUTION HISTORY |
||||
| DATE | ENT CD | ENT TYPE | DESCRIPTION | ENT NUM |
| 06/24/2014 | XAEC | I | EXAMINER'S AMENDMENT ENTERED | 008 |
| 06/24/2014 | GNEN | O | NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED | 007 |
| 06/24/2014 | GNEA | F | EXAMINERS AMENDMENT E-MAILED | 006 |
| 06/24/2014 | CNEA | R | EXAMINERS AMENDMENT -WRITTEN | 005 |
| 06/16/2014 | DOCK | D | ASSIGNED TO EXAMINER | 004 |
| 04/18/2014 | MDSC | E | NOTICE OF DESIGN SEARCH CODE E-MAILED | 003 |
| 04/17/2014 | NWOS | I | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM | 002 |
| 04/08/2014 | NWAP | I | NEW APPLICATION ENTERED IN TRAM | 001 |
CURRENT CORRESPONDENCE INFORMATION |
|
| ATTORNEY | Maury M. Tepper, III |
| CORRESPONDENCE ADDRESS | MAURY M. TEPPER, III TEPPER & EYSTER, PLLC 3724 BENSON DR RALEIGH, NC 27609-7321 |
| DOMESTIC REPRESENTATIVE | Novartis Pharmaceuticals Corporation |